Clinical Characteristics of Cerebrovascular Pathology with Patients Suffering from Ph-Negative Myeloproliferative Disease | Citedby Results | Cerebrovascular Diseases Extra | Karger Publishers

Skip to Main Content

Skip Nav Destination

Clinical Characteristics of Cerebrovascular Pathology with Patients Suffering from Ph-Negative Myeloproliferative Disease

Cerebrovasc Dis Extra (2017) 6 (3): 66–70.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Национальные клинические рекомендации по диагностике и лечению Ph-негативных миелопролиферативных новообразований (истинной полицитемии, эссенциальной тромбоцитемии, первичного миелофиброза) (редакция 2024 г.)

Анаит Левоновна Меликян
И. Н. Суборцева
А. М. Ковригина
В. А. Шуваев
Е. В. Морозова
Е. Г. Ломаиа
В. В. Байков
О. Ю. Виноградова
С. В. Грицаев
Т. И. Ионова
П. И. Кузнецова
Л. А. Кузьмина
И. С. Мартынкевич
Т. А. Митина
Е. С. Полушкина
Т. И. Поспелова
М. А. Соколова
А. Б. Судариков
М. М. Танашян
А. Г. Туркина
Ю. В. Шатохин
Р. Г. Шмаков
Е. Н. Паровичникова

Clinical Oncohematology (2024) 17 (3): 291.

JAK2 V617F Mutation and Large Cerebral Artery Disease in Patients with Myeloproliferative Neoplasms

Naoki Oyama
Takanori Iwamoto
Keito Doyu
Saki Miyazato
Tomoko Okazaki
Seiko Yamada
Toshinori Kondo
Hideho Wada
Yoshiki Yagita

Journal of Atherosclerosis and Thrombosis (2023) 30 (12): 1917.

A case of chorea with cognitive impairment associated with polycythemia vera

Yu. A. Shpilyukova
O. V. Smetanina
A. A. Kolpina
S. N. Illarioshkin

Neurology, Neuropsychiatry, Psychosomatics (2023) 15 (6): 101.

Clinical and Radiological Profile of Cerebrovascular Disease in Polycythemia: Analysis of Neurologic Manifestations from a Tertiary Center in South India

Vivek Bhat
Thanmayi GS
Sanjukta S Rao
G.R.K. Sarma
Sai Kanth Deepalam

Journal of Stroke and Cerebrovascular Diseases (2022) 31 (1): 106167.

Clinical characteristics and brain MRI findings in myeloproliferative neoplasms

Koichiro Nagai
Takashi Shimoyama
Hiroki Yamaguchi
Yuki Sakamoto
Satoshi Suda
Satoshi Wakita
Yasuhiro Nishiyama
Koiti Inokuchi
Kazumi Kimura

Journal of the Neurological Sciences (2020) 416: 116990.

Expanding the possibilities of antithrombotic therapy of cerebrovascular pathology

M.M. Tanashyan
P.I. Kuznetsova
A.A. Raskurazhev

Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova (2020) 120 (4): 123.

Brain MRI-findings in Ph - negative myeloproliferative disorders

M M Tanashyan
A L Melikyan
P I Kuznetsova
A A Raskurazhev
A A Shabalina
R N Konovalov

Terapevticheskii arkhiv (2019) 91 (7): 29.

Cerebrovascular Disorders Associated with Ph-Negative Myeloproliferative Diseases

M.M. Tanashyan
Polina Igorevna Kuznetsova
A.L. Melikyan
A.A. Raskurazhev

Clinical oncohematology (2019) 12 (4): 38.

Prevention of Cerebrovascular Disease in Patients with Myeloproliferatie Disorders

M. M. Tanashyan
P. I. Kuznetsova
A. A. Shabalina
A. A. Raskurazhev

Human Physiology (2018) 44 (8): 896.

Acute ischemic stroke in the setting of essential thrombocytemia (clinical cases)

M M TANASHYAN
P I KUZNETSOVA
A A RASKURAZHEV
I N SUBORTSEVA
A L MELIKYAN

Terapevticheskii arkhiv (2018) 90 (7): 102.

Prevention of cerebrovascular disease in patients with myeloproliferatie disorders

Marine M. Tanashyan
Polina I. Kuznetsova
Alla A. Shabalina
Anton A. Raskurazhev

Annals of Clinical and Experimental Neurology (2017) 11 (3): 23.

Prevention of cerebrovascular disease in patients with myeloproliferatie disorders

Marine M. Tanashyan
Polina I. Kuznetsova
Alla A. Shabalina
Anton A. Raskurazhev

Annals of Clinical and Experimental Neurology (2017) 11 (3): 23.